BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10700533)

  • 1. Antioxidant and immune status in active Crohn's disease. A possible relationship.
    Reimund JM; Hirth C; Koehl C; Baumann R; Duclos B
    Clin Nutr; 2000 Feb; 19(1):43-8. PubMed ID: 10700533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune activation and nutritional status in adult Crohn's disease patients.
    Reimund JM; Arondel Y; Escalin G; Finck G; Baumann R; Duclos B
    Dig Liver Dis; 2005 Jun; 37(6):424-31. PubMed ID: 15893281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
    Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
    Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
    Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamins and trace elements in home parenteral nutrition patients.
    Reimund JM; Arondel Y; Duclos B; Baumann R
    J Nutr Health Aging; 2000; 4(1):13-8. PubMed ID: 10828935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour necrosis factor alpha, lipid peroxidation and NO* are increased and associated with decreased free-radical scavenging enzymes in patients with Weill-Marchesani syndrome.
    Evereklioglu C; Turkoz Y; Calis M; Duygulu F; Karabulut AB
    Mediators Inflamm; 2004 Jun; 13(3):165-70. PubMed ID: 15223607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor-alpha, interleukin-2 soluble receptor and different inflammatory parameters in patients with rheumatoid arthritis.
    Fröde TS; Tenconi P; Debiasi MR; Medeiros YS
    Mediators Inflamm; 2002 Dec; 11(6):345-9. PubMed ID: 12581498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis.
    Sarban S; Kocyigit A; Yazar M; Isikan UE
    Clin Biochem; 2005 Nov; 38(11):981-6. PubMed ID: 16150434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia.
    Zuo XL; Chen JM; Zhou X; Li XZ; Mei GY
    Biol Trace Elem Res; 2006; 114(1-3):41-53. PubMed ID: 17205986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.
    Trebble TM; Wootton SA; Stroud MA; Mullee MA; Calder PC; Fine DR; Moniz C; Arden NK
    Aliment Pharmacol Ther; 2004 May; 19(10):1063-71. PubMed ID: 15142195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
    Grüngreiff K; Reinhold D; Ansorge S
    Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated to hypermanganesemia in patients receiving home parenteral nutrition.
    Reimund JM; Dietemann JL; Warter JM; Baumann R; Duclos B
    Clin Nutr; 2000 Oct; 19(5):343-8. PubMed ID: 11031073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of antioxidants in patients with acute pancreatitis and in patients operated for colorectal cancer: a clinical study.
    Musil F; Zadák Z; Solichová D; Hyspler R; Kaska M; Sobotka L; Manák J
    Nutrition; 2005 Feb; 21(2):118-24. PubMed ID: 15723737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant status in acute stroke patients and patients at stroke risk.
    Zimmermann C; Winnefeld K; Streck S; Roskos M; Haberl RL
    Eur Neurol; 2004; 51(3):157-61. PubMed ID: 15073440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mononuclear cell activation in Crohn's disease. Evaluation using serum assay of neopterin and interleukin-2 soluble receptors].
    Duclos B; Reimund JM; Lang JM; Coumaros G; Chamouard P; Lehr L; Baumann R; Koehl C; Weill JP
    Gastroenterol Clin Biol; 1990; 14(1):22-7. PubMed ID: 2311849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assay of trace elements in the serum by the PIXE method in patients with Crohn's disease].
    Deflandre J; Weber G; Delbrouck JM; Roelandts I; Robaye G; Brassinne A
    Gastroenterol Clin Biol; 1985 Oct; 9(10):719-25. PubMed ID: 2998916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis.
    Guven M; Ozturk B; Sayal A; Ozeturk A; Ulutin T
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):155-62. PubMed ID: 10738911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidant and antioxidant levels in preterm newborns with idiopathic hyperbilirubinaemia.
    Turgut M; Başaran O; Cekmen M; Karataş F; Kurt A; Aygün AD
    J Paediatr Child Health; 2004 Nov; 40(11):633-7. PubMed ID: 15469533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn's disease.
    Akobeng AK; Richmond K; Miller V; Thomas AG
    Clin Nutr; 2007 Feb; 26(1):51-6. PubMed ID: 17161887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.